CO6612239A2 - Derivados de ácido carboxílico que comprenden un anillo de oxazolopiridina 2,5-sustituido - Google Patents

Derivados de ácido carboxílico que comprenden un anillo de oxazolopiridina 2,5-sustituido

Info

Publication number
CO6612239A2
CO6612239A2 CO12125684A CO12125684A CO6612239A2 CO 6612239 A2 CO6612239 A2 CO 6612239A2 CO 12125684 A CO12125684 A CO 12125684A CO 12125684 A CO12125684 A CO 12125684A CO 6612239 A2 CO6612239 A2 CO 6612239A2
Authority
CO
Colombia
Prior art keywords
substituted
carboxylic acid
acid derivatives
oxazolopyridine ring
oxazolopyridine
Prior art date
Application number
CO12125684A
Other languages
English (en)
Inventor
Dieter Kadereit
Matthias Schaefer
Stephanie Hachtel
Axel Dietrich
Thomas Huebschle
Katrin Hiss
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of CO6612239A2 publication Critical patent/CO6612239A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a compuestos de oxazolopirimidina de la fórmula I,en la que A, R, R, Ry X se definen como se ha indicado en las reivindicaciones. Los compuestos de la fórmula I son adecuados, p. ej., para la curación de heridas.
CO12125684A 2010-01-14 2012-07-26 Derivados de ácido carboxílico que comprenden un anillo de oxazolopiridina 2,5-sustituido CO6612239A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10305042 2010-01-14

Publications (1)

Publication Number Publication Date
CO6612239A2 true CO6612239A2 (es) 2013-02-01

Family

ID=41800578

Family Applications (1)

Application Number Title Priority Date Filing Date
CO12125684A CO6612239A2 (es) 2010-01-14 2012-07-26 Derivados de ácido carboxílico que comprenden un anillo de oxazolopiridina 2,5-sustituido

Country Status (31)

Country Link
US (1) US8846692B2 (es)
EP (1) EP2523962B1 (es)
JP (1) JP5841067B2 (es)
KR (1) KR101759128B1 (es)
CN (1) CN102791717B (es)
AR (1) AR079997A1 (es)
AU (1) AU2011206615B2 (es)
BR (1) BR112012017437B1 (es)
CA (1) CA2784560C (es)
CL (1) CL2012001972A1 (es)
CO (1) CO6612239A2 (es)
CY (1) CY1115055T1 (es)
DK (1) DK2523962T3 (es)
ES (1) ES2441954T3 (es)
HK (1) HK1178885A1 (es)
HR (1) HRP20140179T1 (es)
IL (1) IL220720A (es)
MA (1) MA33917B1 (es)
MX (1) MX2012007834A (es)
MY (1) MY156550A (es)
NZ (1) NZ601113A (es)
PL (1) PL2523962T3 (es)
PT (1) PT2523962E (es)
RS (1) RS53254B (es)
RU (1) RU2564018C2 (es)
SG (1) SG182484A1 (es)
SI (1) SI2523962T1 (es)
TW (1) TWI510242B (es)
UY (1) UY33179A (es)
WO (1) WO2011086079A1 (es)
ZA (1) ZA201204174B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR079980A1 (es) 2010-01-13 2012-03-07 Sanofi Aventis Derivados de oxazolopirimidina sustituida en 2,5,7
UY33177A (es) 2010-01-13 2011-08-31 Sanofi Aventis Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido
SG182474A1 (en) * 2010-01-14 2012-08-30 Sanofi Sa Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
EP2523963B1 (de) 2010-01-14 2014-08-27 Sanofi 2,5-substituierte oxazolopyrimidinderivate als edg-1 agonisten
US9321787B2 (en) * 2011-07-07 2016-04-26 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring
EP2862574A1 (en) * 2013-10-15 2015-04-22 Sanofi {4-[5-(3-chloro-phenoxy)-oxazolo[5,4 d]pyrimidin-2-yl]-2,6-dimethyl-phenoxy}-acetic acid for use in the prevention or treatment of acute kidney injury

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679682A (en) * 1970-04-23 1972-07-25 Fmc Corp CERTAIN 5H-ISOXAZOLO{8 5,4-d{9 PYRIMIDIN-4-ONES
JPH01242587A (ja) * 1988-03-25 1989-09-27 Sankyo Co Ltd 縮環オキサゾロチエノピリミジン誘導体
EP1622913A1 (en) * 2003-04-25 2006-02-08 University College Cardiff Consultants, Ltd. Heterocyclic compounds for use in the treatment of viral infections
WO2004096757A1 (en) * 2003-04-30 2004-11-11 Novartis Ag Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
CL2004001120A1 (es) * 2003-05-19 2005-04-15 Irm Llc Compuestos derivados de amina sustituidas con heterociclos, inmunosupresores; composicion farmaceutica; y uso para tratar enfermedades mediadas por interacciones de linfocito, tales como enfermedades autoinmunes, inflamatorias, infecciosas, cancer.
SI1638551T1 (sl) * 2003-05-19 2012-04-30 Irm Llc Imunosupresivne spojine in sestavki
CA2619101A1 (en) * 2005-08-23 2007-03-01 Irm Llc Immunosuppressant compounds and compositions
AU2007227278B2 (en) * 2007-03-21 2014-09-11 Epix Pharmaceuticals, Inc. SIP receptor modulating compounds and use thereof
TW201000099A (en) * 2008-06-20 2010-01-01 Amgen Inc S1P1 receptor agonists and use thereof
CA2730843A1 (en) * 2008-07-15 2010-01-21 Sanofi-Aventis Oxazolopyrimidines as edg-1 receptor agonists
AR079980A1 (es) * 2010-01-13 2012-03-07 Sanofi Aventis Derivados de oxazolopirimidina sustituida en 2,5,7
UY33177A (es) * 2010-01-13 2011-08-31 Sanofi Aventis Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido
UY33178A (es) * 2010-01-13 2011-08-31 Sanofi Aventis Derivados de ácido carboxílico heteroxíclicos que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido
EP2523963B1 (de) * 2010-01-14 2014-08-27 Sanofi 2,5-substituierte oxazolopyrimidinderivate als edg-1 agonisten
SG182474A1 (en) * 2010-01-14 2012-08-30 Sanofi Sa Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring

Also Published As

Publication number Publication date
NZ601113A (en) 2013-07-26
SI2523962T1 (sl) 2014-02-28
AU2011206615A1 (en) 2012-08-02
RU2564018C2 (ru) 2015-09-27
PT2523962E (pt) 2014-02-06
AR079997A1 (es) 2012-03-07
IL220720A (en) 2015-02-26
MX2012007834A (es) 2012-07-30
KR20120101732A (ko) 2012-09-14
HK1178885A1 (en) 2013-09-19
WO2011086079A1 (de) 2011-07-21
PL2523962T3 (pl) 2014-05-30
JP5841067B2 (ja) 2016-01-06
UY33179A (es) 2011-08-31
CY1115055T1 (el) 2016-12-14
TW201134475A (en) 2011-10-16
US8846692B2 (en) 2014-09-30
CN102791717A (zh) 2012-11-21
EP2523962B1 (de) 2013-11-27
RS53254B (en) 2014-08-29
CN102791717B (zh) 2016-03-30
CA2784560C (en) 2017-12-05
MA33917B1 (fr) 2013-01-02
TWI510242B (zh) 2015-12-01
BR112012017437A2 (pt) 2021-03-02
EP2523962A1 (de) 2012-11-21
AU2011206615B2 (en) 2015-03-19
HRP20140179T1 (hr) 2014-03-28
US20130079358A1 (en) 2013-03-28
KR101759128B1 (ko) 2017-07-18
ZA201204174B (en) 2013-02-27
ES2441954T3 (es) 2014-02-07
CA2784560A1 (en) 2011-07-21
DK2523962T3 (en) 2014-03-10
MY156550A (en) 2016-02-26
CL2012001972A1 (es) 2012-10-19
RU2012134630A (ru) 2014-02-20
SG182484A1 (en) 2012-08-30
BR112012017437B1 (pt) 2022-03-03
IL220720A0 (en) 2012-08-30
JP2013517241A (ja) 2013-05-16

Similar Documents

Publication Publication Date Title
CY1121776T1 (el) C17-αλκανοδιυλιο και παραγωγα αλκενοδιυλιου του ολεανολικου οξεος και μεθοδοι χρησης αυτων
CY1121744T1 (el) Παραγωγα c4-μονομεθυλο-τριτερπενοειδους και μεθοδοι χρησης αυτων
UY33227A (es) Compuestos de pirrolopirimidina como inhibidores de la cdk4/6
UY33176A (es) Derivados de oxazolopirimidina sustituida en 2, 5, 7.
ECSP11011244A (es) Nuevos herbicidas.
CR20120410A (es) Pirrolidina-2-carboxamidas sustituidas
CO6541606A2 (es) Espiroindolinona- pirrolidinas
BR112012033350A2 (pt) "composição e métodos para modular a via de sinalização de wnt"
CO6491116A2 (es) Derivados de 5-fluoropirimidinona
UY32863A (es) COMPUESTOS DE HEXAHIDROOXAZINOPTERINA PARA USO COMO INHIBIDORES DE mTOR
UY34318A (es) ?derivados de isotiazolina útiles como compuestos insecticidas?
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
CO6612239A2 (es) Derivados de ácido carboxílico que comprenden un anillo de oxazolopiridina 2,5-sustituido
ECSP11011218A (es) Herbicidas derivados de ciclopentanodiona.
UY34251A (es) derivados de isoxazolina como compuestos insecticidas.
ECSP11011245A (es) Novedosos herbicidas
CO6852083A2 (es) Indol- y bencimidazolcarboxamidas como insecticidas y acaricidas
MA33948B1 (fr) Dérivés d'acide 3-hétéroaroylamino-propionique substitues par oxygène et leur utilisation en tant qu'agents pharmaceutiques.
ECSP11011485A (es) Espiro-epóxidos como productos intermedios.
UY33177A (es) Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido
CR20150397A (es) Composiciones herbicidas
UY33180A (es) Derivados de ácido carboxílico heterocíclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida.
UY33864A (es) Novedoso Derivado Cristalino de Oxazina
ECSP13012914A (es) Síntesis de derivados de 2-carboxamida-cicloamino-urea
UY33178A (es) Derivados de ácido carboxílico heteroxíclicos que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido